K Square Life Sciences Private Limited
About K Square Life Sciences Private Limited
Data last updated:
K Square Life Sciences Private Limited is a private limited company based in Gaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51101UP2012PTC051000. Its GSTIN is 09AAECK8870D1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Vineeta and Rashmi Gupta.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 602 Shipra Krishna Vista Indrapuram, Gaziabad, Uttar Pradesh, India – 201014.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹13.98 Lakh (net margin 6.7%) and EBITDA of ₹22.35 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
K Square Life Sciences Private Limited's registered office is in Gaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 602 Shipra Krishna Vista Indrapuram, Gaziabad, Uttar Pradesh, India – 201014
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of K Square Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of K Square Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of K Square Life Sciences Private Limited, buy the company report.
Financials of K Square Life Sciences Private Limited
FY 2025 filings availableK Square Life Sciences Private Limited reported revenue of ₹2.1 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 12% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of K Square Life Sciences Private Limited, buy the company report.
Board of directors of K Square Life Sciences Private Limited
K Square Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vineeta | Director | 14 Jun 2012 | 14 Years 4 Months | Current |
| Rashmi Gupta Also directs: Navratna City Developers Private Limited | Director | 14 Jun 2012 | 14 Years 4 Months | Current |
| Nandita Tripathi | Director | 05 Feb 2013 | 13 Years 8 Months | Current |
| Sanjay Tripathi | Director | 05 Feb 2013 | 13 Years 8 Months | Current |
Peer comparison
K Square Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jupiven Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Aeclat Lifesciences Private Limited | ₹2.1 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Newwill Biotech Private Limited | ₹2.1 Cr (FY 2025) | 13.0% | Bangalore, Karnataka, India | |||
| K Square Life Sciences Private Limitedthis company | ₹2.1 Cr (FY 2025) | ₹13.98 Lakh | 6.7% | 12.0% | Gaziabad, Uttar Pradesh, India | |
| Pharma Corner Private Limited | ₹2.1 Cr (FY 2025) | 7.0% | Hathras, Uttar Pradesh, India | |||
| Lotus Medicare Services Private Limited | ₹2.1 Cr (FY 2017) | 4.0% | Bangalore, Karnataka, India |
To see the full peer comparison of K Square Life Sciences Private Limited, buy the company report.
Auditor
K Square Life Sciences Private Limited is audited by M BADAL AND ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M BADAL AND ASSOCIATES | FY 2019 | 012698C |
Shareholding
The shareholding of K Square Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of K Square Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving K Square Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for K Square Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
K Square Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECK8870D1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of K Square Life Sciences Private Limited, buy the company report.
Recent activity
K Square Life Sciences Private Limited has 5 board changes on record since 2012: 4 appointments and 1 cessation. The latest: Atul Dubey ceased to be Director on 05 Feb 2013.
Frequently asked questions
K Square Life Sciences is an active private limited company based in Gaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 2012 (14+ years old) and is registered under CIN U51101UP2012PTC051000.
K Square Life Sciences has 4 current directors:
- Vineeta - Director
- Rashmi Gupta - Director
- Nandita Tripathi - Director
- Sanjay Tripathi - Director
The latest financial statements of K Square Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of K Square Life Sciences is 09AAECK8870D1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of K Square Life Sciences is U51101UP2012PTC051000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
K Square Life Sciences was incorporated on 14 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of K Square Life Sciences by revenue are Jupiven Pharmaceuticals Private Limited, Aeclat Lifesciences Private Limited, Newwill Biotech Private Limited, Pharma Corner Private Limited, Lotus Medicare Services Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Atul Dubey ceased to be Director on 05 Feb 2013. Nandita Tripathi was appointed as Director on 05 Feb 2013. Sanjay Tripathi was appointed as Director on 05 Feb 2013. K Square Life Sciences has 5 board changes on record in total.
The registered office of K Square Life Sciences is at F – 602 Shipra Krishna Vista Indrapuram, Gaziabad, Uttar Pradesh, India – 201014.
K Square Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of K Square Life Sciences is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.